Stada Group
Ambarish Vadher has extensive experience in the pharmaceutical industry, specializing in process validation and optimization for peak efficiency and quality. Ambarish has held various roles at companies such as STADA Group, Cipla, Glenmark Pharmaceuticals Ltd., Piramal Healthcare Ltd., and Alembic Research Center. Additionally, Ambarish holds a postgraduate diploma in Patent Law from the National Academy of Legal Studies & Research (NALSAR) University and a Master's degree in Pharmaceutics from Sardar Patel University.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.